ABY-029 imaging for high-grade glioma surgery
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a new imaging agent called ABY-029 during surgery for high-grade glioma (a type of brain tumor). It helps doctors see the tumor more clearly, which may improve removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a suspected high-grade glioma (a serious brain tumor) based on scans.
- Your tumor is planned for open surgery to remove it.
- You are not pregnant or breastfeeding.
- You are not taking any treatments that target the EGFR protein.
- Your kidney and liver function tests are within normal limits (checked before surgery).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a special imaging agent called ABY-029 that is given before surgery for head and neck cancer. The goal is to see if it can help surgeons see the tumor more clearly during the operation.
This trial tests a special fluorescent dye (FG001) that helps surgeons see and remove high-grade brain tumors more completely during surgery. The dye is injected before surgery and glows under special light, potentially helping surgeons remove more tumor tissue safely.
This trial uses advanced imaging to help surgeons remove as much of a malignant brain tumor as safely possible. It may be a good fit if you have a new diagnosis of glioblastoma or a certain astrocytoma and are healthy enough for surgery.
This trial tests if a special dye attached to the immunotherapy drug nivolumab can help surgeons see tumor cells during surgery for high grade glioma. You may join if you are scheduled for surgery and your organs are working well.
This trial is testing a new way to find and remove glioblastoma brain tumors using a special MRI scan. It may help doctors remove more of the tumor safely during surgery.
This trial uses special imaging to tell the difference between real brain tumor growth and a treatment reaction that looks like a tumor. It may help you and your doctor decide if a biopsy is needed.
Hear when a new Intracranial Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.